A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences ASCO 2019: Entrectinib gets edge over crizotinib against ROS1 lung cancer June 4, 2019 Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…